Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses. Jul 2009 - Cancer Immunol. Immunother.; 58(10):1432-0851 [PMID:19221746] [Zhou J] [Weng D] [Zhou F] [Pan K] [Song H] [Wang Q] [Wang H] [Wang H] [Li Y] [Huang L] [Zhang H] [Huang W] [Xia J]
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Apr 2007 - Int. J. Cancer; 120(11):0020-7136 [PMID:17294445] [Guo J] [Zhu J] [Sheng X] [Wang X] [Qu L] [Han Y] [Liu Y] [Zhang H] [Huo L] [Zhang S] [Lin B] [Yang Z]
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Jan 2007 - Clin. Exp. Immunol.; 147(2):0009-9104 [PMID:17223969] [Shi M] [Qian S] [Chen WW] [Zhang H] [Zhang B] [Tang ZR] [Zhang Z] [Wang FS]
Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA. Feb 2006 - Cell. Immunol.; 238(1):0008-8749 [PMID:16472793] [Zhang L] [Zhang H] [Liu W] [Wang H] [Jia J] [Si X] [Ren J]
Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes. Sep 2005 - Immunol. Invest.; 34(3):0882-0139 [PMID:16136780] [Zhang H] [Wang W] [Zhang S] [Huang W]
